DR. WILLIAM STEINBRINK, M.D.
Medical Practice at Stone Creek Dr, Erie, PA
License number
Pennsylvania MD021669E
Category
Medical Practice
Type
Gynecology
Address
Address
4235 Stone Creek Dr, Erie, PA 16506
Phone
(814) 440-1196
Personal information
See more information about WILLIAM STEINBRINK at radaris.comName
Address
Phone
4235 Stone Creek Dr, Erie, PA 16506
3018 Evanston Ave, Erie, PA 16506
4235 Stone Creek Dr, Erie, PA 16506
3211 Liberty St, Erie, PA 16508
1608 Shore Dr, Erie, PA 16505
Organization information
See more information about WILLIAM STEINBRINK at bizstanding.comWilliam Steinbrink MD
140 W 2 St, Erie, PA 16507
Phone:
(814) 453-2772 (Phone)
William Harry Steinbrink
Professional information
See more information about WILLIAM STEINBRINK at trustoria.com
Systems And Methods For Rf-Induced Hyperthermia Using Biological Cells And Nanoparticles As Rf Enhancer Carriers
Systems And Methods For Rf-Induced Hyperthermia Using Biological Cells And Nanoparticles As Rf Enhancer Carriers
US Patent:
2005025, Nov 10, 2005
Filed:
Feb 3, 2005
Appl. No.:
11/050481
Inventors:
John Kanzius - Erie PA, US
William Steinbrink - Erie PA, US
Robert McDonald - Sanibel FL, US
Michael Keating - Houston TX, US
William Steinbrink - Erie PA, US
Robert McDonald - Sanibel FL, US
Michael Keating - Houston TX, US
International Classification:
A61F002/00
US Classification:
607101000
Abstract:
A method of inducing hyperthermia in at least a portion of a target area—e.g., a tumor or a portion of a tumor or targeted cancerous cells—is provided. Targeted RF absorption enhancers, e.g., tumor infiltrating lymphocytes (TILs) containing RF absorbing particles, are introduced into a patient. These targeted RF absorption enhancers will target certain cells in the target areas and enhance the effect of a hyperthermia generating RF signal directed toward the target area. The targeted RF absorption enhancers may, in a manner of speaking, add one or more RF absorption frequencies to cells in the target area, which will permit a hyperthermia generating RF signal at that frequency or frequencies to heat the targeted cells.
Systems And Methods For Combined Rf-Induced Hyperthermia And Radioimmunotherapy
Systems And Methods For Combined Rf-Induced Hyperthermia And Radioimmunotherapy
US Patent:
2005027, Dec 8, 2005
Filed:
Feb 3, 2005
Appl. No.:
11/050478
Inventors:
John Kanzius - Erie PA, US
William Steinbrink - Erie PA, US
Robert McDonald - Sanibel FL, US
Michael Keating - Houston TX, US
William Steinbrink - Erie PA, US
Robert McDonald - Sanibel FL, US
Michael Keating - Houston TX, US
International Classification:
A61F002/00
US Classification:
607101000
Abstract:
A combined radiotherapy and hyperthermia therapy is provided, including inducing hyperthermia in at least a portion of a target area—e.g., a tumor or a portion of a tumor or targeted cancerous cells—is provided. Biomolecules labeled with at least one radionuclide suitable for radiotherapy are provided and introduced into a patient; targeted RF absorption enhancers are provided and introduced into a patient; and a hyperthermia generating RF signal is directed via toward the target cells, thereby warming the radionuclide-labeled biomolecules and targeted RF absorption enhancers bound to target cells. The targeted RF absorption enhancers may, in a manner of speaking, add one or more RF absorption frequencies to cells in the target area, which will permit a hyperthermia generating RF signal at that frequency or frequencies to heat the targeted cells. Biomolecules labeled with at least one radionuclide suitable for radiotherapy may be used for both radiotherapy and as RF absorption enhancers for the hyperthermia generating RF signal.